Home » Stocks » OPK

OPKO Health, Inc. (OPK)

Stock Price: $3.76 USD 0.06 (1.49%)
Updated Jun 21, 2021 1:03 PM EDT - Market open
Market Cap 2.55B
Revenue (ttm) 1.77B
Net Income (ttm) 120.80M
Shares Out 640.85M
EPS (ttm) 0.19
PE Ratio 19.87
Forward PE 16.08
Dividend n/a
Dividend Yield n/a
Trading Day June 21
Last Price $3.76
Previous Close $3.70
Change ($) 0.06
Change (%) 1.49%
Day's Open 3.76
Day's Range 3.69 - 3.78
Day's Volume 1,849,434
52-Week Range 2.38 - 6.47

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

OPKO Health (OPK) expects to improve its business efficacy and focus on oral solid dose products post the sale of its Ireland facility.

1 hour ago - Zacks Investment Research

OPKO Health Inc's (NASDAQ: OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in patients with stage 3/4 chronic kidney disease with Ni...

2 hours ago - Benzinga

MIAMI, June 21, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its subsidiary EirGen Pharma has entered into an agreement with Nicoya Macau Limited, an affiliate of Nicoya...

5 hours ago - GlobeNewsWire

OPKO Health Inc's (NASDAQ: OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics plc (NASDAQ: HZNP) for $65 million. The facility ho...

4 days ago - Benzinga

MIAMI, June 17, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in Wate...

4 days ago - GlobeNewsWire

OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?

3 weeks ago - Zacks Investment Research

MIAMI, May 27, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 1-4, 2021. Ma...

3 weeks ago - GlobeNewsWire

MIAMI, May 24, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced a transfer of the licensed rights to RAYALDEE® in Japan from Japan Tobacco Inc. (JT) to Vifor Fresenius Medical Ca...

4 weeks ago - GlobeNewsWire

Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.

1 month ago - Zacks Investment Research

Looking for penny stocks to buy during a market correction? Check these 4 out for your watchlist The post Best Penny Stocks to Buy During a Market Correction?

Other stocks mentioned: CYRN, NERV, WTRH
1 month ago - PennyStocks

MIAMI, May 07, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has entered into exchange agreements with certain noteholders of the Company's 4.50% Convertible Senior Notes due 2025 (“Notes”). ...

1 month ago - GlobeNewsWire

OPKO Health's (OPK) first-quarter results benefit from strength in diagnostics.

1 month ago - Zacks Investment Research

OPKO Health (OPK) delivered earnings and revenue surprises of 0.00% and 8.39%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Shares of OPKO Health (NASDAQ:OPK) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 155.56% over the past year to $0.05, which were in line w...

1 month ago - Benzinga

Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today

1 month ago - GlobeNewsWire

OPKO Health's (OPK) BioReference expands its major league sports relationships with the announcement of COVID-19 testing agreement with MLB.

2 months ago - Zacks Investment Research

OPKO Health's (OPK) BioReference expands COVID-19 testing in schools to create a safer learning environment for students, teachers, staff and their families.

2 months ago - Zacks Investment Research

ELMWOOD PARK, N.J., March 26, 2021 /PRNewswire/ --  BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the expansion of its COVID-19 school testing program to support...

2 months ago - PRNewsWire

OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?

3 months ago - Zacks Investment Research

These penny stocks have more than just a low price point. They have Wall Street analysts backing up those prices with high price targets.

Other stocks mentioned: ATNX, BLU, CPRX, NBEV, SPPI, UEC
3 months ago - InvestorPlace

These seven penny stocks are most likely to push through the $5 mark having built a significant head of steam in the past year. The post 7 Penny Stocks Close To Busting Through the $5 Mark appeared firs...

Other stocks mentioned: LIVX, LLNW, NOK, OGI, WTRH
3 months ago - InvestorPlace

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week.

Other stocks mentioned: ADC, CAR, ZTS, AAT, INCY, MTEM, RPRX ...
3 months ago - Benzinga

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorizatio...

Other stocks mentioned: PFE
3 months ago - Business Wire

With the crazy bullishness in the market, you can't find too many discounted plays. However, these sleeper stocks might just give your portfolio the kickstart it needs in 2021.

Other stocks mentioned: AHEXY, AMRN, EATBF, KELYA, LLNW, SKX, SWCH
3 months ago - InvestorPlace

NEW YORK, Feb. 22, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locatio...

3 months ago - PRNewsWire

OPKO Health's (OPK) fourth-quarter results benefit from strength in diagnostics.

4 months ago - Zacks Investment Research

Opko Health Inc (NASDAQ: OPK) reported Q4 results that came in above expectations with EPS of $0.05 beating the estimate of $0.04 and sales of $494.6 million higher than the consensus of $443.1 million....

4 months ago - Benzinga

Hint: Investors are more focused on concerns about the future than successes of the recent past.

4 months ago - The Motley Fool

OPKO Health (OPK) delivered earnings and revenue surprises of 25.00% and 13.41%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

Shares of OPKO Health (NASDAQ:OPK) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 266.67% over the past year to $0.05, which beat the estim...

4 months ago - Benzinga

OPKO Health's (OPK) fourth-quarter results are likely to reflect solid performance from Services and Products segment and RAYALDEE.

4 months ago - Zacks Investment Research

MIAMI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2020, as well as discuss financial guidan...

4 months ago - GlobeNewsWire

The movement of retail traders against hedge funds has caused several stocks to spike. Many of the top movers have been stocks that have a high percentage of their floated shares short, causing what's k...

Other stocks mentioned: CLVS, DVAX, LCI, NAKD, PGEN, SENS, TXMD ...
4 months ago - Benzinga

Penny stocks are cheap for a reason, as there are obvious flaws. However, with those flows comes opportunity.

Other stocks mentioned: CAIXY, CLVS, DHT, MBIO, RNWK, RYCEY
5 months ago - InvestorPlace

OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.

5 months ago - Zacks Investment Research

OPKO Health, Inc. (OPK) CEO Phil Frost Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

5 months ago - Seeking Alpha

ELMWOOD PARK, N.J., Jan. 13, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced Scarlet Health™, an in-home, fully integrated digital platform pr...

5 months ago - PRNewsWire

Calls on Analysts and Stockholders Attending J.P. Morgan's Healthcare Conference to Determine Whether Management Disputes our Analysis and Stands by Original 4Q'20 Guidance Calls on Analysts and Stockho...

5 months ago - GlobeNewsWire

OPKO Health (OPK) closed the most recent trading day at $4.48, moving +1.82% from the previous trading session.

5 months ago - Zacks Investment Research

It's the perfect time for a wealthy CEO to ride off into the sunset.

5 months ago - The Motley Fool

MIAMI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39th Annual J.P. Morgan Healthcare Conference being held virtually o...

5 months ago - GlobeNewsWire

OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.

5 months ago - Zacks Investment Research

ELMWOOD PARK, N.J., Jan. 4, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools thr...

5 months ago - PRNewsWire

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics...

Other stocks mentioned: PFE
5 months ago - Business Wire

OPKO Health has been experiencing an historic year in terms of business achievements, execution, and public recognition. The current Opko share price has been trading at extremely depressed levels recen...

5 months ago - Seeking Alpha

These interesting low-cost stocks have the opportunity to grow.

Other stocks mentioned: ATRS, FLNT
5 months ago - The Motley Fool

MIAMI, Dec. 21, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Roger Medel, M.D. as an independent member of its Board of Directors, effective December 18, 2...

6 months ago - GlobeNewsWire

Having college and professional athletes play sports during a pandemic can create logistics problems with social distancing and COVID-19 testing. Two small cap companies have won contracts to help leagu...

Other stocks mentioned: PAE
6 months ago - Benzinga

Rumors of a potential sale of the company's growth hormone royalty stream excited investors.

6 months ago - The Motley Fool

OPKO Health, Inc. (OPK) Management Presents at Jefferies 2020 Virtual London Healthcare Conference (Transcript)

7 months ago - Seeking Alpha

About OPK

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Nov 2, 1995
CEO
Phillip Frost
Employees
5,269
Stock Exchange
NASDAQ
Ticker Symbol
OPK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for OPKO Health stock is "Buy." The 12-month stock price forecast is 8.25, which is an increase of 119.71% from the latest price.

Price Target
$8.25
(119.71% upside)
Analyst Consensus: Buy